Perioperative Glycemic Control

Anesthesiology Clinics

Volumn 30, Issue 3, 2012, Pages 445-466

  Russo, Nicholas ^a,b  

^a Medina General Hospital   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Blood glucose; Diabetes mellitus; Glycemic control; Surgery

Indexed keywords

CYCLOSPORIN; GLUCOCORTICOID; GLUCOSE; IMMUNOSUPPRESSIVE AGENT; INSULIN; TACROLIMUS;

ALGORITHM; ANEMIA; BLOOD GLUCOSE MONITORING; BLOOD TRANSFUSION; CONTINUOUS INFUSION; CORONARY ARTERY BYPASS GRAFT; CRITICALLY ILL PATIENT; DIABETIC PATIENT; ELECTIVE SURGERY; ERYTHROCYTE TRANSFUSION; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INTENSIVE CARE; KIDNEY FAILURE; LABORATORY TEST; MEDICAL DEVICE; MORBIDITY; PATHOPHYSIOLOGY; PERIOPERATIVE COMPLICATION; PEROPERATIVE CARE; POLYNEUROPATHY; POSTOPERATIVE CARE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETROSPECTIVE STUDY; REVIEW; SURGICAL INFECTION; SURGICAL MORTALITY; THORAX SURGERY;

BLOOD GLUCOSE; CRITICAL ILLNESS; DIABETES MELLITUS; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INTRAOPERATIVE PERIOD; PERIOPERATIVE CARE; POSTOPERATIVE PERIOD;

EID: 84866389591     PISSN: 19322275     EISSN: 22103538     Source Type: Journal    
DOI: 10.1016/j.anclin.2012.07.007     Document Type: Review

References (89)

1. Inzucchi S.E. Clinical practice. Management of hyperglycemia in the hospital setting. N Engl J Med 2006, 355:1903-1911.
2. American Diabetes Association Standards of medical care in diabetes-2009. Diabetes Care 2009, 32(Suppl 1):S13-S61.
3. Cowie C.C., Rust K.F., Ford E.S., et al. Full accounting of diabetes and pre-diabetes in the U.S. population in 1988-1994 and 2005-2006. Diabetes Care 2009, 32:287-294.
4. Fahy B.G., Sheehy A.M., Coursin D.B. Glucose control in the intensive care unit. Crit Care Med 2009, 37:1769-1776.
5. Hertzer N.R., Bena J.F., Karafa M.T. A personal experience with the influence of diabetes and other factors on the outcome of infrainguinal bypass grafts for occlusive disease. J Vasc Surg 2007, 46:271-279.
6. Bagry H.S., Raghavendran S., Carli F. Metabolic syndrome and insulin resistance: perioperative considerations. Anesthesiology 2008, 108:506-523.
7. Puskas F., Grocott H.P., White W.D., et al. Intraoperative hyperglycemia and cognitive decline after CABG. Ann Thorac Surg 2007, 84:1467-1473.
8. Bochicchio G.V., Sung J., Joshi M., et al. Persistent hyperglycemia is predictive of outcome in critically ill trauma patients. J Trauma 2005, 58:921-924.
9. Bochicchio G.V., Salzano L., Joshi M., et al. Admission preoperative glucose is predictive of morbidity and mortality in trauma patients who require immediate operative intervention. Am Surg 2005, 71:171-174.
10. The UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998, 352:837-853.
11. Fietsam R., Bassett J., Glover J.L. Complications of coronary artery surgery in diabetic patients. Am Surg 1991, 57:551-557.
12. Zerr K.J., Fumary A.P., Grunkemeier G.L., et al. Glucose control lowers the risk of wound infection in diabetics after open-heart operations. Ann Thorac Surg 1997, 63(2):356-361.
13. Pomposelli J.J., Baxter J.K., Babineau T.J., et al. Early postoperative glucose control predicts nosocomial infection rate in diabetic patients. JPEN J Parenter Enteral Nutr 1998, 22:77-81.
14. Golden S.H., Peart-Vigilance C., Kao W.H., et al. Perioperative glycemic control and the risk of infectious complications in a cohort of adults with diabetes. Diabetes Care 1999, 22:1408-1414.
15. Furnary A.P., Zerr K.J., Grunkemeier G.L., et al. Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. Ann Thorac Surg 1999, 67:352-362.
16. Trick W.E., Scheckler W.E., Tokars J.E., et al. Modifiable risk factors associated with deep sternal site infection after coronary artery bypass grafting. J Thorac Cardiovasc Surg 2000, 119:108-114.
17. Trick W.E., Scheckler W.E., Tokars J.E., et al. Risk factors for radial artery harvest site infection following coronary artery bypass graft surgery. Clin Infect Dis 2000, 30:270-275.
18. Latham R., Lancaster A.D., Covington J.F., et al. The association of diabetes and glucose control with surgical- site infections among cardiothoracic surgery patients. Infect Control Hosp Epidemiol 2001, 22:607-612.
19. Estrada C.A., Young J.A., Nifong L.W., et al. Outcomes and perioperative hyperglycemia in patients with or without diabetes mellitus undergoing coronary artery bypass grafting. Ann Thorac Surg 2003, 75:1932-1939.
20. Wheat L.J. Infection and diabetes mellitus. Diabetes Care 1980, 3:187-197.
21. Khaodhiar L., McCowen K., Bistrian B. Perioperative hyperglycemia, infection or risk?. Curr Opin Clin Nutr Metab Care 1999, 2:79-82.
22. Rayfield E.J., Ault M.J., Keusch G.T., et al. Infection and diabetes: the case for glucose control. Am J Med 1982, 72:439-450.
23. Alexiewicz J.M., Kumar D., Smogorzewski M., et al. Polymorphonuclear leukocytes in non-insulin-dependent diabetes mellitus: abnormalities in metabolism and function. Ann Intern Med 1995, 123:919-924.
24. Bagdade J.D., Root R.K., Bulger R.J. Impaired leukocyte function in patients with poorly controlled diabetes. Diabetes 1974, 23:9-15.
25. Wilson R.M. Neutrophil function in diabetes. Diabet Med 1986, 3:509-512.
26. Browne J.A., Cook C., Pietrobon R., et al. Diabetes and early postoperative outcomes following lumbar fusion. Spine 2007, 32:2214-2219.
27. Perner A., Nielsen S.E., Rask-Madsen J. High glucose impairs superoxide production from isolated blood neutrophils. Intensive Care Med 2003, 29:642-645.
28. Noordzij P.G., Boersma E., Schreiner F., et al. Increased preoperative glucose levels are associated with perioperative mortality in patients undergoing noncardiac, nonvascular surgery. Eur J Endocrinol 2007, 156:137-142.
29. Yendamuri S., Fulda G.J., Tinkoff G.H. Admission hyperglycemia as a prognostic indicator in trauma. J Trauma 2003, 55:33-38.
30. Umpierrez G.E., Isaacs S.D., Bazargan N., et al. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab 2002, 87:978-982.
31. McGirt M.J., Woodworm G.F., Brooke B.S., et al. Hyperglycemia independently increases the risk of perioperative stroke, myocardial infarction, and death after carotid endarterectomy. Neurosurgery 2006, 58:1066-1073.
32. Van den Berghe G., Wouters P., Weekers F., et al. Intensive insulin therapy in the critically ill patients. N Engl J Med 2001, 345:1359-1367.
33. Ouattara A., Lecomte P., Le Manach Y., et al. Poor intraoperative blood glucose control is associated with a worsened hospital outcome after cardiac surgery in diabetic patients. Anesthesiology 2005, 103:687-694.
34. Gandhi G.Y., Nuttall G.A., Abel M.D., et al. Intraoperative hyperglycemia and perioperative outcomes in cardiac surgery patients. Mayo Clin Proc 2005, 80:862-866.
35. Doenst T., Wijcysundera D., Karkouti K., et al. Hyperglycemia during cardiopulmonary bypass is an independent risk factor for mortality in patients undergoing cardiac surgery. J Thorac Cardiovasc Surg 2005, 130. 1144.el-1144.e8.
36. Van den Berghe G., Wouters P.J., Bouillon R., et al. Outcome benefit of intensive insulin therapy in critically ill patients: insulin dose versus glycemic control. Crit Care Med 2003, 31(3):59-66.
37. Finney S.J., Zekveld C., Elia A., et al. Glucose control and mortality in critically ill patients. JAMA 2003, 290:2041-2047.
38. Krinsley J.S. Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. Mayo Clin Proc 2003, 78:1471-1478.
39. Krinsley J.S. Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. Mayo Clin Proc 2004, 79:992-1000.
40. Hansen T.K., Thiel S., Wouters P.J., et al. Intensive insulin therapy exerts anti-inflammatory effects in critically ill patients and counteracts the adverse effect of low mannose-binding lectin levels. J Clin Endocrinol Metab 2003, 88:1082-1088.
41. Weekers F., Giulietti A., Michalaki M., et al. Metabolic, endocrine, and immune effects of stress hyperglycemia in a rabbit model of prolonged critical illness. Endocrinology 2003, 144:5329-5338.
42. Groeneveld A.B., Beinshuizen A., Visser F.C. Insulin: a wonder drug in the critically ill?. Crit Care 2002, 6:102-105.
43. Van den Berghe G., Wilmer A., Hermans G., et al. Intensive insulin therapy in the medical ICU. N Engl J Med 2006, 354:449-461.
44. Brunkhorst F.M., Engel C., Bloos F., German Competence Network Sepsis (Sep- Net), et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008, 358:125-139.
45. Preiser J.C. Restoring normoglycaemia: not so harmless. Crit Care 2008, 12:116.
46. Gandhi G.Y., Nuttall G.A., Abel M.D., et al. Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery: a randomized trial. Ann Intern Med 2007, 146:233-243.
47. Knapke C.M., Owens J.P., Mirtallo J.M. Management of glucose abnormalities in patients receiving total parenteral nutrition. Clin Pharm 1989, 8:136-144.
48. Mizock B.A. Alterations in fuel metabolism in critical illness: hyperglycemia. Best Pract Res Clin Endocrinol Metab 2001, 15:533-551.
49. Wolfe R.R. Carbohydrate metabolism in critically ill patients: implications for nutritional support. Crit Care Clin 1987, 3:ll-24.
50. Metabolic basis of nutrition in intensive care unit patients: ten critical questions. Intensive Care Med 2002, 28:1512-1520. The ESICM Working Group.
51. Schricker T., Lattermann R., Fiset P., et al. Integrated analysis of protein and glucose metabolism during surgery: effects of anesthesia. J Appl Physiol 2001, 91:2523-2530.
52. Thorell A., Efendic S., Gutniak M., et al. Insulin resistance after abdominal surgery. Br J Surg 1994, 81:59-63.
53. Clarke R.S. The hyperglycaemic response to different types of surgery and anaesthesia. Br J Anaesth 1970, 42:45-53.
54. Thorell A., Efendic S., Gutniak M., et al. Development of postoperative insulin resistance is associated with the magnitude of operation. Eur J Surg 1993, 159:593-599.
55. Thorell A., Nygren J., Essen P., et al. The metabolic response to cholecystectomy: insulin resistance after open compared with laparoscopic operation. Eur J Surg 1996, 162:187-191.
56. Schricker T., Berroth A., Pfeiffer U., et al. Influence of vaginal versus abdominal hysterectomy on perioperative glucose metabolism. Anesth Analg 1996, 83:991-995.
57. Rassias A.J. Intraoperative management of hyperglycemia in the cardiac surgical patient. Semin Thorac Cardiovasc Surg 2006, 18:330-338.
58. Lipshultz A.K., Gropper M.A. Perioperative glycemic control: an evidence-based review. Anesthesiology 2009, 110:408-421.
59. Vriesendorp T.M., van Santen S., DeVries J.H., et al. Predisposing factors for hypoglycemia in the intensive care unit. Crit Care Med 2006, 34:96-101.
60. Krinsley J.S., Grover A. Severe hypoglycemia in critically ill patients: risk factors and outcomes. Crit Care Med 2007, 35:2262-2267.
61. Preiser JC. Intensive glycemic control in Med-Surg patients (European Glucontrol Trial) [abstract]. In Program and abstracts of the Society of Critical Care Medicine 36th Critical Care Congress. Orlando, February 17-21, 2007.
62. Malmberg K., Ryden L., Hamsten A., et al. Effects of insulin treatment on cause-specific one-year mortality and morbidity in diabetic patients with acute myocardial infarction. DIGAMI study group, diabetes insulin-glucose in acute myocardial infarction. Eur Heart J 1996, 17:1337-1344.
63. Scott J.F., Robinson G.M., French J.M., et al. Glucose potassium insulin infusions in the treatment of acute stroke patients with mild to moderate hyperglycemia: the glucose insulin in stroke trial (GIST). Stroke 1999, 30:793-799.
64. Lazar H.L., Philippides G., Fitzgerald C., et al. Glucose-insulin-potassium solutions enhance recovery after urgent coronary artery bypass grafting. J Thorac Cardiovasc Surg 1997, 113:354-360. [discussion: 360-2].
65. Rao V., Christakis G.T., Weisel R.D., et al. The Insulin Cardioplegia Trial: myocardial protection for urgent coronary artery bypass grafting. J Thorac Cardiovasc Surg 2002, 123:928-935.
66. Lazar H.L., Chipkin S., Philippides G., et al. Glucose-insulin- potassium solutions improve outcomes in diabetics who have coronary artery operations. Ann Thorac Surg 2000, 70:145-150.
67. Furnary A.P., Wu Y., Bookin S.O. Effect of hyperglycemia and continuous intravenous insulin infusions on outcomes of cardiac surgical procedures: the Portland Diabetic Project. Endocr Pract 2004, 10(Suppl 2):21-33.
68. Furnary A.P., Gao G., Grunkemeier G.L., et al. Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg 2003, 125:1007-1021.
69. D'Alessandro C., Leprince P., Golmard J.L., et al. Strict glycemic control reduces EuroSCORE expected mortality in diabetic patients undergoing myocardial revascularization. J Thorac Cardiovasc Surg 2007, 134:29-37.
70. Lazar H.L., Chipkin S.R., Fitzgerald C.A., et al. Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation 2004, 109:1497-1502.
71. Bilotta F., Spinelli A., Giovannini F., et al. The effect of intensive insulin therapy on infection rate, vasospasm, neurologic outcome, and mortality in neurointensive care unit after intracranial aneurysm clipping in patients with acute subarachnoid hemorrhage: a randomized prospective pilot trial. J Neurosurg Anesthesiol 2007, 19:156-160.
72. Bellomo R., Egi M. What is a NICE-SUGAR for patients in the intensive care unit?. Mayo Clin Proc 2009, 84:400-402.
73. Finfer S., Chittock D.R., Su S.Y., et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009, 360:1283-1297.
74. Wiener R.S., Wiener D.C., Larson R.J. Benefits and risks of tight glucose control in critically ill adults: a meta-analysis. JAMA 2008, 300:933-944.
75. Lacherade J.C., Jabre P., Bastuji-Garin S., et al. Failure to achieve glycemic control despite intensive insulin therapy in a medical ICU: incidence and influence on ICU mortality. Intensive Care Med 2007, 33:814-821.
76. Nasraway S.A. Sitting on the horns of a dilemma: avoiding severe hypoglycemia while practicing tight glycemic control. Crit Care Med 2007, 35:2435-2437.
77. Egi M., Bellomo R., Stachowski E., et al. Variability of blood glucose concentration and short-term mortality in critically ill patients. Anesthesiology 2006, 105:244-252.
78. Ali N., O'Brien J., Dungan K., et al. Glucose variability is independently associated with mortality in patients with sepsis. Crit Care Med 2007, 36:A257.
79. Monnier L., Mas E., Ginet C., et al. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA 2006, 295:1681-1687.
80. Egi M., Bellomo R., Stachowski E., et al. Intensive insulin therapy in postoperative intensive care unit patients: a decision analysis. Am J Respir Crit Care Med 2006, 173:407-413.
81. Desachy A., Vuagnat A.C., Ghazali A.D., et al. Accuracy of bedside glucometry in critically ill patients: influence of clinical characteristics and perfusion index. Mayo Clin Proc 2008, 83:400-405.
82. Kanji S., Buffie J., Hutton B., et al. Reliability of point-of-care testing for glucose measurement in critically ill adults. Crit Care Med 2005, 33:2778-2785.
83. Chaney M.A., Nikolov M.P., Blakeman B.P., et al. Attempting to maintain normoglycemia during cardiopulmonary bypass with insulin may initiate postoperative hypoglycemia. Anesth Analg 1999, 89:1091-1095.
84. Meijering S., Corstjens A.M., Tulleken J.E., et al. Towards a feasible algorithm for tight glycaemic control in critically ill patients: a systematic review of the literature. Crit Care 2006, 10:R19.
85. Guvener M., Pasaoglu I., Demircin M., et al. Perioperative hyperglycemia is a strong correlate of postoperative infection in type II diabetic patients after coronary artery bypass grafting. Endocr J 2002, 49:531-537.
86. Van den Berghe G., Wilmer A., Milants I., et al. Intensive insulin therapy in mixed medical/surgical intensive care units: benefit versus harm. Diabetes 2006, 55:3151-3159.
87. Toft P., Jorgensen H.S., Toennesen E., et al. Intensive insulin therapy to non-cardiac ICU patients: a prospective study. Eur J Anaethesiol 2006, 23:705-709.
88. Ingels C., Debaveye Y., Milants I., et al. Strict blood glucose control with insulin during intensive care after cardiac surgery: impact on 4-years survival, dependency on medical care, and quality-of-life. Eur Heart J 2006, 27:2716-2724.
89. Preiser J.C., Devos P., Ruiz-Santana S., et al. A prospective randomised multi-center controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive Care Med 2009, 35(10):1738-1748.